The election or approval of the appointment of each individual named in the Director Election Proposal, subject in each case to the conditions set forth in the Proxy Statement, was also approved by the Company’s stockholders at the Annual Meeting. The votes for, votes withheld and brokernon-votes for each director nominee are set forth below:
| | | | | | |
Director Nominee | | Votes for | | Votes Withheld | | Broker Non- Votes |
Todd Builione | | 155,110,053 | | 7,992,019 | | 46,789,109 |
Frederick Arnold | | 155,047,824 | | 8,054,248 | | 46,789,109 |
Michael Hagan | | 155,118,011 | | 7,984,061 | | 46,789,109 |
Jerel Hopkins | | 155,068,192 | | 8,033,880 | | 46,789,109 |
Todd Builione, Frederick Arnold, Michael Hagan and Jerel Hopkins Have each been elected and qualified to serve for a three-year term expiring at the 2022 annual meeting of the stockholders.
The Auditor Ratification Proposal was also approved by the Company’s stockholders at the Annual Meeting. The votes for, votes against, abstentions and brokernon-votes are set forth below:
| | | | | | |
Votes For | | Votes Against | | Abstentions | | Broker Non-Votes |
199,657,773 | | 3,108,119 | | 7,125,289 | | 0 |
On November 6, 2019, the Company adjourned the Annual Meeting with respect to (i) the Merger Charter Amendment Proposal 1 and (ii) the Merger Charter Amendment Proposal 2 to permit additional time to solicit stockholder votes for such proposals. The reconvened meeting (the “Reconvened Meeting”) will be held on November 22, 2019 at 1:00 p.m., Eastern Time, at 201 Rouse Boulevard, Philadelphia, Pennsylvania 19112. Valid proxies submitted prior to the Annual Meeting will continue to be valid for the Reconvened Meeting, unless properly changed or revoked prior to votes being taken at the Reconvened Meeting. The record date of August 8, 2019 will remain the same for the Reconvened Meeting.
Forward-Looking Statements
Statements included herein may constitute “forward-looking” statements as that term is defined in Section 27A of the Securities Act and Section 21E of the Exchange Act, including statements with regard to future events or the future performance or operations of FSIC II, the Company, FSIC IV and CCT II (together with FSIC II, the Company, FSIC IV and CCT II, the “Funds”). Words such as “believes,” “expects,” “projects,” and “future” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. Certain factors could cause actual results to differ materially from those projected in these forward-looking statements. Factors that could cause actual results to differ materially include changes in the economy, risks associated with possible disruption to a Fund’s operations or the economy generally due to terrorism or natural disasters, future changes in laws or regulations and conditions in a Fund’s operating area, failure to obtain requisite shareholder approval for the Fund Proposals (as defined below) set forth in the Proxy Statement, failure to consummate the business combination transaction involving the Funds, uncertainties as to the timing of the consummation of the business combination transaction involving the Funds, unexpected costs, charges or expenses resulting from the business combination transaction involving the Funds, failure to realize the anticipated benefits of the business combination transaction involving the Funds, failure to consummate the recapitalization transaction and failure to list the common stock of the combined entity on a national securities exchange. Some of these factors are enumerated in the filings the Funds make with the U.S. Securities and Exchange Commission (the “SEC”) and are also be contained in the Proxy Statement. The inclusion of forward-looking statements should not be regarded as a representation that any plans, estimates or expectations will be achieved. Any forward-looking statements speak only as of the date of this communication. Except as required by federal securities laws, the Funds undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on any of these forward-looking statements.